• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二价奥司他韦类似物作为有效的流感神经氨酸酶抑制剂。

Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.

机构信息

Research Centre of Modern Analytical Technology, Tianjin University of Science & Technology, No. 29, 13th Avenue, TEDA, Tianjin, 300457, China.

China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science and Technology, No. 29, 13th Avenue, TEDA, Tianjin, 300457, China.

出版信息

Carbohydr Res. 2019 May 15;477:32-38. doi: 10.1016/j.carres.2019.03.012. Epub 2019 Apr 1.

DOI:10.1016/j.carres.2019.03.012
PMID:30954773
Abstract

A panel of divalent oseltamivir and guanidino oseltamivir analogues with esterification on the carboxyl acid group as potent inhibitors of influenza virus neuraminidase was prepared via click reaction. The primary structure activity relationship study demonstrated that appropriate distance between two oseltamivir monomers around 30 Å can crosslink two adjacent neuraminidase tetramers on the virion surface and result in highly effective NA inhibitors against three strains of influenza virus and H7N9 virus like particle. This strategy also provides a basis for the multivalent modification on oseltamivir.

摘要

通过点击反应,制备了一组带有羧酸酯化的二价奥司他韦和胍基奥司他韦类似物作为流感病毒神经氨酸酶的有效抑制剂。初步的结构活性关系研究表明,两个奥司他韦单体之间约 30Å 的适当距离可以交联病毒表面上的两个相邻的神经氨酸酶四聚体,并导致对三种流感病毒株和 H7N9 病毒样颗粒具有高度有效的 NA 抑制剂。该策略还为奥司他韦的多价修饰提供了基础。

相似文献

1
Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.二价奥司他韦类似物作为有效的流感神经氨酸酶抑制剂。
Carbohydr Res. 2019 May 15;477:32-38. doi: 10.1016/j.carres.2019.03.012. Epub 2019 Apr 1.
2
Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.新型 N-取代奥司他韦衍生物作为有效的流感神经氨酸酶抑制剂:设计、合成、生物评价、ADME 预测和分子对接研究。
Eur J Med Chem. 2019 Nov 15;182:111635. doi: 10.1016/j.ejmech.2019.111635. Epub 2019 Aug 22.
3
Synthesis and biological evaluation of NH-acyl oseltamivir analogues as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的NH-酰基奥司他韦类似物的合成及生物学评价
Eur J Med Chem. 2017 Dec 1;141:648-656. doi: 10.1016/j.ejmech.2017.10.004. Epub 2017 Oct 5.
4
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.发现针对 150 腔的高活性和选择性流感病毒神经氨酸酶抑制剂。
Eur J Med Chem. 2021 Feb 15;212:113097. doi: 10.1016/j.ejmech.2020.113097. Epub 2020 Dec 13.
5
A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus.一种磷酸奥司他韦-生物素缀合物作为流感病毒的强效选择性黏附剂。
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1805-7. doi: 10.1016/j.bmcl.2014.02.021. Epub 2014 Feb 18.
6
Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.发现一种非两性离子奥司他韦类似物作为有效的流感 A 神经氨酸酶抑制剂。
Eur J Med Chem. 2020 Aug 15;200:112423. doi: 10.1016/j.ejmech.2020.112423. Epub 2020 May 12.
7
Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.羟肟酸奥司他韦和酰基磺酰胺衍生物作为流感神经氨酸酶抑制剂
Bioorg Med Chem. 2014 Dec 1;22(23):6647-6654. doi: 10.1016/j.bmc.2014.10.005.
8
Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.设计、合成并评价了含有吡啶基的奥司他韦衍生物作为抗流感 A 神经氨酸酶的抑制剂。
Eur J Med Chem. 2020 Jan 1;185:111841. doi: 10.1016/j.ejmech.2019.111841. Epub 2019 Nov 2.
9
Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.发现 C-1 修饰的奥司他韦衍生物作为有效的流感神经氨酸酶抑制剂。
Eur J Med Chem. 2018 Feb 25;146:220-231. doi: 10.1016/j.ejmech.2018.01.050. Epub 2018 Feb 4.
10
Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.生物素化、荧光素化和“点击化学”偶联的磷酰奥司他韦类似物作为流感病毒探针,利用其对神经氨酸酶的选择性结合。
Org Biomol Chem. 2011 Aug 21;9(16):5625-9. doi: 10.1039/c1ob05384a. Epub 2011 Jun 30.

引用本文的文献

1
Sialidases as Potential Therapeutic Targets for Treatment of a Number of Human Diseases.唾液酸酶作为治疗多种人类疾病的潜在治疗靶点。
Int J Mol Sci. 2025 Sep 8;26(17):8733. doi: 10.3390/ijms26178733.
2
Sialidase Inhibitors with Different Mechanisms.唾液酸酶抑制剂的不同作用机制。
J Med Chem. 2022 Oct 27;65(20):13574-13593. doi: 10.1021/acs.jmedchem.2c01258. Epub 2022 Oct 17.
3
Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors.二价抑制剂混合抑制神经氨酸酶和血凝素预防甲型流感病毒感染。
J Med Chem. 2022 May 26;65(10):7312-7323. doi: 10.1021/acs.jmedchem.2c00319. Epub 2022 May 12.
4
Ramified derivatives of 5-(perylen-3-ylethynyl)uracil-1-acetic acid and their antiviral properties.5-(苝-3-基乙炔基)尿嘧啶-1-乙酸的分支衍生物及其抗病毒特性。
RSC Adv. 2019 Aug 20;9(45):26014-26023. doi: 10.1039/c9ra06313g. eCollection 2019 Aug 19.
5
Recent progress in chemical approaches for the development of novel neuraminidase inhibitors.新型神经氨酸酶抑制剂开发的化学方法的最新进展。
RSC Adv. 2021 Jan 6;11(3):1804-1840. doi: 10.1039/d0ra07283d. eCollection 2021 Jan 4.
6
Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease.唾液酸酶和唾液酸转移酶抑制剂:针对致病性和疾病
Front Mol Biosci. 2021 Jul 29;8:705133. doi: 10.3389/fmolb.2021.705133. eCollection 2021.